Abstract

Bisphenol chemicals are commonly used in the manufacturing of polycarbonate plastics, polyvinyl chloride plastics, resins, and thermal printing applications. Humans are inadvertently exposed to bisphenols through contact with consumer products and/or medical devices. Recent reports have shown a link between bisphenol-a (BPA) exposure and adverse cardiovascular outcomes; although these studies have been limited to adult subjects and models. Since cardiac physiology differs significantly between the developing and adult heart, we aimed to assess the impact of BPA exposure on cardiac function, using a neonatal cardiomyocyte model. Neonatal rat ventricular myocytes were monitored to assess cell viability, spontaneous beating rate, beat rate variability, and calcium-handling parameters in the presence of control or bisphenol-supplemented media. A range of doses were tested to mimic environmental exposure (10−9–10−8M), maximum clinical exposure (10−5M), and supraphysiological exposure levels (10−4M). Acute BPA exposure altered cardiomyocyte functionality, resulting in a slowed spontaneous beating rate and increased beat rate variability. BPA exposure also impaired intracellular calcium handling, resulting in diminished calcium transient amplitudes, prolonged calcium transient upstroke and duration time. Alterations in calcium handling also increased the propensity for alternans and skipped beats. Notably, the effect of BPA-treatment on calcium handling was partially reversible. Our data suggest that acute BPA exposure could precipitate secondary adverse effects on contractile performance and/or electrical alternans, both of which are dependent on intracellular calcium homeostasis.

Details

Title
Disruption of neonatal cardiomyocyte physiology following exposure to bisphenol-a
Author
Ramadan, Manelle 1 ; Sherman, Meredith 2 ; Jaimes, Rafael, III 1 ; Chaluvadi, Ashika 2 ; Swift, Luther 1 ; Nikki Gillum Posnack 3 

 Sheikh Zayed Institute for Pediatric and Surgical Innovation, Children’s National Health System, Washington, USA; Children’s National Heart Institute, Children’s National Health System, Washington, USA 
 Sheikh Zayed Institute for Pediatric and Surgical Innovation, Children’s National Health System, Washington, USA 
 Sheikh Zayed Institute for Pediatric and Surgical Innovation, Children’s National Health System, Washington, USA; Children’s National Heart Institute, Children’s National Health System, Washington, USA; Department of Pediatrics, Department of Pharmacology & Physiology, School of Medicine and Health Sciences, George Washington University, Washington, USA 
Pages
1-11
Publication year
2018
Publication date
May 2018
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2036770806
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.